Lipid emulsion-LipidRescue™ therapy in the treatment of systemic poisoning.
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Lipid emulsion (Primary)
- Indications Poisoning
- Focus Therapeutic Use
- 08 Jun 2016 New trial record
- 20 May 2016 According to ResQ Pharma media release, the Company has submitted an Investigational New Drug (IND) application for LipidRescue™ Therapy (LRT) as a last resort in treating local anesthetic systematic toxicity (LAST) to U.S. Food & Drug Administration (FDA).